Connection

Kayla Ponder to Liver

This is a "connection" page, showing publications Kayla Ponder has written about Liver.
Connection Strength

0.845
  1. Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy. J Clin Invest. 1998 Jun 15; 101(12):2831-41.
    View in: PubMed
    Score: 0.091
  2. Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood. 1997 Feb 15; 89(4):1254-9.
    View in: PubMed
    Score: 0.083
  3. Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver. Hum Gene Ther. 1996 Nov 10; 7(17):2113-21.
    View in: PubMed
    Score: 0.082
  4. Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from Ras-transduced livers resemble the effects of insulin. Hepatology. 1996 Oct; 24(4):838-48.
    View in: PubMed
    Score: 0.081
  5. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther. 1996 Mar 20; 7(5):637-45.
    View in: PubMed
    Score: 0.078
  6. Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream. Hepatology. 1995 Jul; 22(1):160-8.
    View in: PubMed
    Score: 0.074
  7. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood. 1994 Nov 15; 84(10):3394-404.
    View in: PubMed
    Score: 0.071
  8. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A. 1994 Feb 15; 91(4):1460-4.
    View in: PubMed
    Score: 0.067
  9. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A. 1991 Feb 15; 88(4):1217-21.
    View in: PubMed
    Score: 0.055
  10. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum Gene Ther. 1991; 2(1):41-52.
    View in: PubMed
    Score: 0.054
  11. Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice. Hum Gene Ther. 1999 Apr 10; 10(6):911-22.
    View in: PubMed
    Score: 0.024
  12. Retroviral vector sequences may interact with some internal promoters and influence expression. Hum Gene Ther. 1996 Jan 20; 7(2):159-71.
    View in: PubMed
    Score: 0.019
  13. Optimization of liver-directed retroviral gene delivery. Transplant Proc. 1994 Dec; 26(6):3379-80.
    View in: PubMed
    Score: 0.018
  14. Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res. 1994 Jun; 56(6):510-7.
    View in: PubMed
    Score: 0.017
  15. In vivo hepatocyte transduction with retrovirus during in-flow occlusion. J Surg Res. 1993 May; 54(5):418-25.
    View in: PubMed
    Score: 0.016
  16. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A. 1992 Jan 01; 89(1):89-93.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.